Related Experiment Video
Updated: May 26, 2026
11:05
Analysis of Oxidative Stress in Zebrafish Embryos
Published on: July 7, 2014
A dominant negative zebrafish Ahr2 partially protects developing zebrafish from dioxin toxicity
Kevin A Lanham1, Amy L Prasch, Kasia M Weina
1Department of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, United States of America.
Plos One
|December 24, 2011
Summary
Dominant-negative aryl hydrocarbon receptors (dnAHRs) were developed to block 2,3,7,8 tetrachlorodibenzo-p-dioxin (TCDD) toxicity. These dnAHRs successfully reduced TCDD
Area of Science:
- Toxicology
- Molecular Biology
- Genetics
Background:
- 2,3,7,8 tetrachlorodibenzo-p-dioxin (TCDD) toxicity is mediated by the aryl hydrocarbon receptor (AHR).
- The precise mechanisms linking AHR activation to TCDD-induced toxicity remain poorly understood.
- Targeted manipulation of AHR activity in vivo is crucial for elucidating its toxicological pathways.
Purpose of the Study:
- To construct and characterize dominant-negative zebrafish Ahr2 (dnAhr2) variants.
- To assess the efficacy of dnAHRs in mitigating TCDD-induced toxicity in vivo.
- To validate dnAHRs as a tool for blocking AHR-mediated toxic effects.
Main Methods:
- Engineered dnAhr2 constructs by modifying the zebrafish Ahr2 gene, either by deleting the C-terminal transactivation domain or replacing it with the Drosophila engrailed repressor domain.
- Generated transgenic zebrafish expressing a selected dnAhr2 under the control of the ubiquitous e2fα promoter.
- Quantified TCDD induction of the Ahr2 target gene cyp1a using 7-ethoxyresorufin-O-deethylase (EROD) activity assays.
- Evaluated TCDD-induced cardiotoxicity, including pericardial edema, heart malformation, and reduced blood flow, in both wild-type and transgenic zebrafish.
Main Results:
- Transgenic zebrafish expressing dnAhr2 exhibited reduced TCDD induction of cyp1a gene expression, as indicated by lower EROD activity.
- The cardiotoxic effects of TCDD, such as pericardial edema and heart malformations, were significantly mitigated in zebrafish expressing dnAhr2.
- Reduced blood flow, another TCDD-induced cardiotoxicity, was also ameliorated in the dnAhr2 transgenic zebrafish.
Conclusions:
- Dominant-negative AHRs (dnAHRs) are effective tools for manipulating AHR activity in vivo.
- dnAHRs can successfully block TCDD-induced toxicity, including cardiotoxicity, in a whole organism model.
- This study provides in vivo proof-of-principle for using dnAHRs as a strategy to counteract AHR-mediated toxicological outcomes.
